![The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120427995-gr2.jpg)
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect
![Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34-Selected Allogeneic HCT - Biology of Blood and Marrow Transplantation Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34-Selected Allogeneic HCT - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2088318860/2074934129/ybbmt54462-fig-0008.jpg)
Combining the Disease Risk Index (DRI) and Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Provides a Comprehensive Prognostic Model for CD34-Selected Allogeneic HCT - Biology of Blood and Marrow Transplantation
![Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma - ScienceDirect Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1083879113011294-gr1.jpg)
Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma - ScienceDirect
![The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120427995-gr1.jpg)
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases - ScienceDirect
![PDF) Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients PDF) Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients](https://i1.rgstatic.net/publication/262845716_Hematopoietic_Cell_Transplantation_Comorbidity_Index_HCT-CI_Is_Predictive_of_Serious_Adverse_Events_and_Overall_Survival_in_Older_Allogeneic_Transplant_Recipients/links/5639c96c08aed5314d22a986/largepreview.png)
PDF) Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients
![Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation | Bone Marrow Transplantation Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbmt.2016.141/MediaObjects/41409_2016_Article_BFbmt2016141_Fig1_HTML.jpg)
Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation | Bone Marrow Transplantation
![Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a2a1f346dc54f6949033dd69f0fb62e06e4bafe/6-Table4-1.png)
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
![Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1658387618300013-gr1.jpg)
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
![Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a2a1f346dc54f6949033dd69f0fb62e06e4bafe/5-Figure2-1.png)
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia | Haematologica
![PDF) Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy PDF) Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy](https://www.researchgate.net/publication/263931181/figure/fig2/AS:507832446525440@1498088098237/Two-year-OS-NRM-using-the-original-HCT-CI-scoring-system-A-Shows-OS-P-14-44-and-B_Q320.jpg)
PDF) Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy
![Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia - Clinical Lymphoma, Myeloma and Leukemia Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia - Clinical Lymphoma, Myeloma and Leukemia](https://www.clinical-lymphoma-myeloma-leukemia.com/cms/asset/c2614ef1-03be-43f5-a5c5-3c6d30d9e0c7/gr1.jpg)
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia - Clinical Lymphoma, Myeloma and Leukemia
![Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a2a1f346dc54f6949033dd69f0fb62e06e4bafe/6-Table3-1.png)
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
![The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT - ScienceDirect The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921005383-grabsf1.jpg)
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT - ScienceDirect
![Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1658387618300013-gr2.jpg)
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
![Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome - Biology of Blood and Marrow Transplantation Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/985fc19d-e0e2-47cc-8a90-4c7fbb7ffb1a/ybbmt54462-fig-0007_lrg.jpg)